サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1520405

血栓管理デバイス市場レポート：製品タイプ、エンドユーザー、地域別、2024年～2032年

Clot Management Devices Market Report by Product Type, End-User, and Region 2024-2032

出版日
発行
IMARC
ページ情報
英文 140 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
血栓管理デバイス市場レポート：製品タイプ、エンドユーザー、地域別、2024年～2032年
出版日: 2024年07月01日
発行: IMARC
ページ情報: 英文 140 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の血栓管理デバイスの市場規模は2023年に18億米ドルに達しました。今後、IMARC Groupは、2024年から2032年にかけて4.8%の成長率（CAGR）を示し、2032年には28億米ドルに達すると予測しています。

血栓管理デバイスとは、肺塞栓症（PE）、動脈血栓、深部静脈血栓症（DVT）などの治療に使用される医療機器を指します。一般的に使用される血栓管理デバイスには、カテーテル直接血栓溶解療法（CDT）機器、塞栓除去バルーンカテーテル、経皮的血栓除去装置、神経血管塞栓除去装置、下大静脈フィルター（IVCF）などがあります。これらのデバイスは、患者の心臓、脳、肺、脚における血栓の発生を抑制し、虚血性脳卒中、激しい脚の痛み、心臓発作の発生を予防します。

世界の血栓管理デバイス市場動向：

心血管疾患（CVDs）の有病率の増加は、世界の老人人口の増加とともに、市場の成長を促進する重要な要因の一つです。座りがちなライフスタイルや不健康な食生活により、心臓疾患やDVT、PEに悩まされる人が増えており、血栓管理デバイスの需要が高まっています。さらに、患者とヘルスケアプロバイダーの両方による低侵襲（MI）処置への嗜好の高まりも、市場の成長を後押ししています。例えば、機械的血栓除去術は、外科医が小さな切開創を通して患者の動脈から血栓を除去するために特殊な機器を使用するMI処置です。これとは別に、カテーテル指示血栓溶解療法を必要とする股関節、膝、脊椎損傷の事例が増加していることも、市場成長にプラスの影響を与えています。その他の要因としては、次世代血栓除去装置の開発などのさまざまな技術の進歩、費用対効果の高い装置の継続的な発売、医療科学分野における広範な研究開発（R&D）活動などがあり、市場をさらに牽引すると予測されます。

本レポートで扱う主な質問

  • 世界の血栓管理デバイス市場はこれまでどのように推移し、今後どのように推移していくのか？
  • 主要な地域市場はどこか？
  • 世界の血栓管理デバイス市場に与えたCOVID-19の影響は何か？
  • 製品タイプ別の市場内訳は何か？
  • エンドユーザー別の市場内訳は何か？
  • 血栓管理デバイス市場産業のバリューチェーンにおける様々な段階とは？
  • 世界の血栓管理デバイス市場の構造と主要プレイヤーとは？
  • 産業における競合の程度とは？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の血栓管理デバイス市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品タイプ別

  • 神経血管塞栓除去デバイス
    • 市場動向
    • 市場予測
  • 塞栓除去バルーンカテーテル
    • 市場動向
    • 市場予測
  • 経皮血栓除去装置
    • 市場動向
    • 主な種類
      • 機械的血栓除去術
      • 吸引血栓除去術
      • 経皮的機械的血栓除去術（PMT）
    • 市場予測
  • カテーテル誘導血栓溶解装置
    • 市場動向
    • 市場予測
  • 下大静脈フィルター
    • 市場動向
    • 主な種類
      • 恒久
      • 一時留置
    • 市場予測

第7章 市場内訳：エンドユーザー別

  • 病院
    • 市場動向
    • 市場予測
  • 診断センターと専門クリニック
    • 市場動向
    • 市場予測

第8章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第9章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第10章 バリューチェーン分析

第11章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第12章 価格指標

第13章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • AngioDynamics Inc.
    • Argon Medical Devices Inc.
    • Boston Scientific Corporation
    • DePuy Synthes Inc.
    • Edwards Lifesciences Corporation
    • iVascular S.L.U.
    • Lemaitre Vascular Inc.
    • Medtronic Inc.
    • Straub Medical AG
    • Stryker Corporation
    • Teleflex Incorporated
    • Vascular Solutions
図表

List of Figures

  • Figure 1: Global: Clot Management Devices Market: Major Drivers and Challenges
  • Figure 2: Global: Clot Management Devices Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Clot Management Devices Market: Breakup by Product Type (in %), 2023
  • Figure 4: Global: Clot Management Devices Market: Breakup by End-User (in %), 2023
  • Figure 5: Global: Clot Management Devices Market: Breakup by Region (in %), 2023
  • Figure 6: Global: Clot Management Devices Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 7: Global: Clot Management Devices (Neurovascular Embolectomy Devices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 8: Global: Clot Management Devices (Neurovascular Embolectomy Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 9: Global: Clot Management Devices (Embolectomy Balloon Catheters) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Clot Management Devices (Embolectomy Balloon Catheters) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Clot Management Devices (Percutaneous Thrombectomy Devices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Clot Management Devices (Percutaneous Thrombectomy Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Clot Management Devices (Catheter-Directed Thrombolysis Devices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Clot Management Devices (Catheter-Directed Thrombolysis Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Clot Management Devices (Inferior Vena Cava Filters) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Clot Management Devices (Inferior Vena Cava Filters) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Clot Management Devices (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Clot Management Devices (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Clot Management Devices (Diagnostic Centers and Specialty Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Clot Management Devices (Diagnostic Centers and Specialty Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: North America: Clot Management Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: North America: Clot Management Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: United States: Clot Management Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: United States: Clot Management Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Canada: Clot Management Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Canada: Clot Management Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Asia Pacific: Clot Management Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Asia Pacific: Clot Management Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: China: Clot Management Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: China: Clot Management Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Japan: Clot Management Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Japan: Clot Management Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: India: Clot Management Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: India: Clot Management Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: South Korea: Clot Management Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: South Korea: Clot Management Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Australia: Clot Management Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Australia: Clot Management Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Indonesia: Clot Management Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Indonesia: Clot Management Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Others: Clot Management Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Others: Clot Management Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Europe: Clot Management Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Europe: Clot Management Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Germany: Clot Management Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Germany: Clot Management Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: France: Clot Management Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: France: Clot Management Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: United Kingdom: Clot Management Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: United Kingdom: Clot Management Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Italy: Clot Management Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Italy: Clot Management Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Spain: Clot Management Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Spain: Clot Management Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Russia: Clot Management Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Russia: Clot Management Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Others: Clot Management Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Others: Clot Management Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Latin America: Clot Management Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Latin America: Clot Management Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Brazil: Clot Management Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Brazil: Clot Management Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Mexico: Clot Management Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Mexico: Clot Management Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Others: Clot Management Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Others: Clot Management Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Middle East and Africa: Clot Management Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Middle East and Africa: Clot Management Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Global: Clot Management Devices Industry: SWOT Analysis
  • Figure 70: Global: Clot Management Devices Industry: Value Chain Analysis
  • Figure 71: Global: Clot Management Devices Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Clot Management Devices Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Clot Management Devices Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
  • Table 3: Global: Clot Management Devices Market Forecast: Breakup by End-User (in Million US$), 2024-2032
  • Table 4: Global: Clot Management Devices Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 5: Global: Clot Management Devices Market Structure
  • Table 6: Global: Clot Management Devices Market: Key Players
目次
Product Code: SR112024A2131

The global clot management devices market size reached US$ 1.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.8 Billion by 2032, exhibiting a growth rate (CAGR) of 4.8% during 2024-2032.

Clot management devices refer to the medical equipment that are used for the treatment of ailments such as pulmonary embolism (PE), arterial blood clots and deep vein thrombosis (DVT). Some of the commonly used clot management devices include catheter-directed thrombolysis (CDT) devices, embolectomy balloon catheters, percutaneous thrombectomy devices, neurovascular embolectomy devices and inferior vena cava filters (IVCFs). These devices aid in inhibiting the development of blood clots in the heart, brain, lungs and legs of the patient, thereby preventing the instances of potential ischemic strokes, severe leg pain and heart attacks.

Global Clot Management Devices Market Trends:

The increasing prevalence of cardiovascular diseases (CVDs), along with the rising geriatric population across the globe, is one of the key factors driving the growth of the market. Owing to the sedentary lifestyles and unhealthy dietary habits, a greater number of individuals are suffering from heart ailments, DVT and PE, thereby enhancing the demand for clot management devices. Furthermore, the growing preference for minimally invasive (MI) procedures by both patients and healthcare providers is also boosting the market growth. For instance, mechanical thrombectomy is an MI procedure in which the surgeon uses specialized equipment to remove the clot from the patient's artery through a small incision. Apart from this, the increasing instances of hip, knee and spinal injuries that require catheter-directed thrombolysis, have also created a positive impact on the market growth. Other factors, including various technological advancements, such as the development of next-generation thrombectomy devices, the continual launch of cost-effective devices, along with extensive research and development (R&D) activities in the field of medical sciences, are projected to drive the market further.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global clot management devices market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product type and end-user.

Breakup by Product Type:

Neurovascular Embolectomy Devices

Embolectomy Balloon Catheters

Percutaneous Thrombectomy Devices

Mechanical Thrombectomy

Aspiration Thrombectomy

Percutaneous Mechanical Thrombectomy (PMT)

Catheter-Directed Thrombolysis Devices

Inferior Vena Cava Filters

Permanent

Retrievable

Breakup by End-User:

Hospitals

Diagnostic Centers and Specialty Clinics

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being AngioDynamics Inc., Argon Medical Devices Inc., Boston Scientific Corporation, DePuy Synthes Inc., Edwards Lifesciences Corporation, iVascular S.L.U., Lemaitre Vascular Inc., Medtronic Inc., Straub Medical AG, Stryker Corporation, Teleflex Incorporated, Vascular Solutions, etc.

Key Questions Answered in This Report:

  • How has the global clot management devices market performed so far and how will it perform in the coming years?
  • What are the key regional markets?
  • What has been the impact of COVID-19 on the global clot management devices market?
  • What is the breakup of the market based on the product type?
  • What is the breakup of the market based on the end-user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global clot management devices market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Clot Management Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Neurovascular Embolectomy Devices
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Embolectomy Balloon Catheters
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Percutaneous Thrombectomy Devices
    • 6.3.1 Market Trends
    • 6.3.2 Major Types
      • 6.3.2.1 Mechanical Thrombectomy
      • 6.3.2.2 Aspiration Thrombectomy
      • 6.3.2.3 Percutaneous Mechanical Thrombectomy (PMT)
    • 6.3.3 Market Forecast
  • 6.4 Catheter-Directed Thrombolysis Devices
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Inferior Vena Cava Filters
    • 6.5.1 Market Trends
    • 6.5.2 Major Types
      • 6.5.2.1 Permanent
      • 6.5.2.2 Retrievable
    • 6.5.3 Market Forecast

7 Market Breakup by End-User

  • 7.1 Hospitals
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Diagnostic Centers and Specialty Clinics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Indicators

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 AngioDynamics Inc.
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Argon Medical Devices Inc.
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
    • 13.3.3 Boston Scientific Corporation
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 DePuy Synthes Inc.
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
    • 13.3.5 Edwards Lifesciences Corporation
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
    • 13.3.6 iVascular S.L.U.
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
    • 13.3.7 Lemaitre Vascular Inc.
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
      • 13.3.7.4 SWOT Analysis
    • 13.3.8 Medtronic Inc.
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
    • 13.3.9 Straub Medical AG
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
    • 13.3.10 Stryker Corporation
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
      • 13.3.10.4 SWOT Analysis
    • 13.3.11 Teleflex Incorporated
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio
      • 13.3.11.3 Financials
      • 13.3.11.4 SWOT Analysis
    • 13.3.12 Vascular Solutions
      • 13.3.12.1 Company Overview
      • 13.3.12.2 Product Portfolio